Avatar

Current Concepts in Chemo Embolization

By Deepak Sudheendra 10 Videos
3,836 views
December 30, 2013
0 Comments
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Related Content

AUTOPLAY
22:02
ACG 2023 Conference Coverage

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

Feat. R. Wong
13:58
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 &am…

Feat. R. Kim, T. Biachi
19:39
The France Foundation

Systemic Treatment Landscape for Advanced HCC: Case Discussion - 40 …

Feat. A. Burgoyne, S. Stein
08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
10:41
Francesco Massari

Treatment Approaches in Bone Metastases Pain Management

09:23
Johns Hopkins

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Feat. M. Yarchoan
09:43
ASCO GI 2023 Conference Coverage

ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. S…

Feat. L. Dawson
33:31
Total Health

Updates in Radiation Therapy for GI Cancers

Feat. N. Sanford
23:39
OncoAlert

Year in Review: Gastric, Esophageal, & Liver Cancers

Feat. S. Gill
14:37
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomized, Double-Blind, Placebo-Control…

Feat. A. Batra
13:45
Flavio Rocha

How to Incorporate Molecular Testing in Therapy for Localized Cholan…

11:25
Total Health

Updates in the Management of Advanced HCC

Feat. T. Heumann
28:30
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in Unresectable HCC: Where Are We and Where…

Feat. D. Li
13:48
Yale Cancer Center

Considerations for 1L Treatment Selection in Advanced HCC: Safety an…

Feat. S. Stein
67:23
The France Foundation

Combining Locoregional and Systemic Therapy for Challenging HCC Cases

Feat. R. Avritscher, A. O. Kaseb
21:26
NYU Langone

Common TKI Toxicity Management in 2L HCC Treatment

Feat. J. Wu
06:04
PrecisCa

What Is the Role for Systemic Chemo vs. IO for the Treatment of Unre…

Feat. R. Finn
16:40
CE Concepts

Immune Checkpoint Inhibition: Utility in HCC and BTC

Feat. K. Kelley
08:43
Integrity Continuing Education

Mixed HCC-Cholangiocarcinoma: Case Presentation and Panel Discussion

Feat. M. Nakazawa, J. Harding, C. Shubert, J. Birkness-Gartman, M. Yarchoan
55:46
University of Colorado Cancer Center

UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Canc…

Feat. L. Davis